Biodesix
BDSX | NASDAQ
$9.00
-$0.88 (-8.91%)
At close: Nov 16, 2026, 4:00 PM ET
$9.36
+$0.36 (+4.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-8.91%
(1D)No price chart data available for 1D timeframe.
Rating
50.2
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #281/1021 (Top 28%)
Key Statistics
Market Data
Market Cap $95.94M
1D Range
8.89 9.86
52W Range
5.46 30.60
Valuation (TTM)
PE -3.26
PB 11.06
EV/EBITDA -9.24
Valuation (NTM)
Forward PE N/A
Forward PEG 0.08
Price Target $35.00
Cash Flow
FCF Yield -19.9%
SBC Adj. FCF Yield -23.9%
SBC Impact -20.2%
Margins
Gross Margin 82.4%
Operating Margin -18.7%
FCF Margin -18.1%
Growth (CAGR)
Revenue 3Y | 5Y 33.7% |
7.2%
Dil EPS 3Y | 5Y 48.0% |
55.7%
FCF 3Y | 5Y 58.6% |
16.9%
Returns
ROA -28.8%
ROE -442.3%
ROIC -24.0%
Financial Health
Net Debt
$44.03M
Current Ratio 2.96
Interest Coverage -2.45
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lun...
Sector Healthcare
Industry Medical - Diagnostics & Research
Employees 334
IPO Date Oct 28, 2020
Website www.biodesix.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.75
Miss -0.19%
YoY:
+35.34% REV
$24.04M
Miss -12.52%
YoY:
+10.44%Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
5
Consensus
Buy
Price Target
$35.00
Upside
+288.89%
Buy (5)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BDSX